CSIMarket
 


Cerus Corporation  (CERS)
Other Ticker:  
 

Cerus's Leverage Ratio

CERS's quarterly Leverage Ratio and Total Liabilities, Equity growth




CERS Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -8.69 % -10.05 % -14.27 % -18.48 % -26.69 %
Y / Y Total Liabilities Change 2.46 % 1.22 % 11.37 % 29.99 % 33.38 %
Leverage Ratio MRQ 1.95 1.86 1.79 1.81 1.73
Overall Ranking # # # # #
Seq. Equity Change -3.5 % -4.59 % -6.15 % 5.67 % -4.94 %
Seq. Total Liabilities Change 1.13 % -1.27 % -6.79 % 10.09 % -0.08 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 1.13%, Leverage Ratio detoriated to 1.95, above company's average Leverage Ratio.

Within Medical Equipment & Supplies industry Cerus Corporation achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are CERS Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Cerus's Equity $ 73 Millions Visit CERS's Balance sheet
Cerus's Total Liabilities $ 142 Millions Visit CERS's Balance sheet
Source of CERS's Sales Visit CERS's Sales by Geography


Cumulative Cerus's Leverage Ratio

CERS's Leverage Ratio for the trailling 12 Months

CERS Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -8.69 % -10.05 % -14.27 % -18.48 % -26.69 %
Y / Y Total Liabilities TTM Growth 2.46 % 1.22 % 11.37 % 29.99 % 33.38 %
Leverage Ratio TTM 1.85 1.8 1.75 1.64 1.45
Total Ranking TTM # 2431 # 2741 # 2740 # 2949 # 2228
Seq. Equity TTM Growth -3.5 % -4.59 % -6.15 % 5.67 % -4.94 %
Seq. Total Liabilities TTM Growth 1.13 % -1.27 % -6.79 % 10.09 % -0.08 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 1.13%, Leverage Ratio improved to 1.85, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 147 other companies have achieved lower Leverage Ratio than Cerus. While Leverage Ratio total ranking has improved so far to 2365, from total ranking in previous quarter at 969.

Explain Leverage Ratio?
Who are CERS Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 148
Healthcare Sector # 788
Within the Market # 2426


TTM Leverage Ratio Statistics
High Average Low
1.85 1.05 0.39
(Sep 30 2022)   (Dec. 30, 2015)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Yunhong Cti Ltd   4.80 $ 13.499  Millions$ 2.815  Millions
Avinger Inc  4.65 $ 23.005  Millions$ 4.946  Millions
Owens and Minor Inc   4.42 $ 4,273.250  Millions$ 966.837  Millions
Insulet Corporation  4.05 $ 1,734.700  Millions$ 428.000  Millions
Baxter International Inc   4.02 $ 22,430.000  Millions$ 5,579.000  Millions
Harpoon Therapeutics Inc   3.94 $ 66.584  Millions$ 16.912  Millions
Escalon Medical Corp   3.26 $ 3.770  Millions$ 1.157  Millions
The Pennant Group Inc   3.21 $ 388.472  Millions$ 120.840  Millions
Better Therapeutics Inc   2.89 $ 20.969  Millions$ 7.252  Millions
Vaso Corporation  2.89 $ 42.007  Millions$ 14.531  Millions
Minerva Surgical Inc   2.86 $ 61.701  Millions$ 21.538  Millions
Invo Bioscience Inc   2.46 $ 3.162  Millions$ 1.287  Millions
Tela Bio Inc   2.41 $ 56.262  Millions$ 23.301  Millions
3m Company  2.21 $ 31,285.000  Millions$ 14,156.000  Millions
Pavmed Inc   2.12 $ 60.492  Millions$ 28.556  Millions
Biolase Inc   2.09 $ 29.007  Millions$ 13.858  Millions
Conmed Corporation  2.04 $ 1,463.129  Millions$ 716.337  Millions
Tessco Technologies Incorporated  1.98 $ 153.103  Millions$ 77.387  Millions
Cerus Corporation  1.95 $ 142.283  Millions$ 73.120  Millions
Artivion Inc   1.91 $ 487.623  Millions$ 255.108  Millions
Silk Road Medical Inc   1.84 $ 105.346  Millions$ 57.198  Millions
Neuropace Inc   1.76 $ 76.373  Millions$ 43.409  Millions
Apollo Endosurgery inc   1.74 $ 73.716  Millions$ 42.314  Millions
Patterson Companies Inc   1.72 $ 1,791.579  Millions$ 1,042.108  Millions
Biosig Technologies Inc   1.68 $ 3.088  Millions$ 1.834  Millions
Dexcom Inc   1.63 $ 2,969.000  Millions$ 1,824.500  Millions
U S Physical Therapy Inc  1.51 $ 481.104  Millions$ 318.604  Millions
Novocure Limited  1.49 $ 664.764  Millions$ 445.401  Millions
Strata Skin Sciences Inc   1.44 $ 31.435  Millions$ 21.800  Millions
Tandem Diabetes Care Inc   1.42 $ 600.604  Millions$ 421.822  Millions

Date modified: 2022-11-06T03:35:36+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PUK's Profile

Stock Price

PUK's Financials

Business Description

Fundamentals

Charts & Quotes

PUK's News

Suppliers

PUK's Competitors

Customers & Markets

Economic Indicators

PUK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071